Published in JAMA, the trial followed patients who had already lost an average of 20% of their body weight over 36 weeks on tirzepatide
We accept cash, credit, debit, CareCredit, and Cherry Financing
The Mayo Clinic data specifically showed benefits with tirzepatide, while other studies demonstrated similar benefits with semaglutide
Supplied strictly for in-vitro and preclinical laboratory research not for human or veterinary use
The mechanism of hunger creates a sensation of hunger when our body needs nutrients and a sensation of satiety when we eat enough

Tirzepatide Read the full profile Receptors activated (GIP + GLP-1 (dual)) Molecular weight (4,813.45 Da) Half-life (~5 days) Average weight loss (SURMOUNT-5, 72 wk) (~20%) Typical starting dose (2.5 mg/week) Typical maintenance dose (515 mg/week) Titration schedule (+2.5 mg every 4 weeks) Given as a weekly shot Available forms (Injection only) FDA-approved (Mounjaro/Zepbound) Brand-name price (no insurance) ($1,000+/month) Compounded price (where available) ($125$278/month) Shared GI side effects (nausea, etc.) Approved for sleep apnea Semaglutide Read the full profile Receptors activated (GLP-1 only) Molecular weight (4,113.64 Da) Half-life (~7 days) Average weight loss (STEP 1, 68 wk) (~15%) FDA-approved for cardiovascular risk reduction Typical starting dose (0.25 mg/week) Typical maintenance dose (2.4 mg/week) Titration schedule (+0.250.5 mg every 4 weeks) Given as a weekly shot Available forms (Injection or oral tablet (Rybelsus)) FDA-approved (Ozempic/Wegovy) Brand-name price (no insurance) ($1,000+/month) Compounded price (where available) ($99$178/month) Shared GI side effects (nausea, etc.) Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
